Swiss pharmaceutical giant Roche said Monday it is accelerating the timeline for its Wegovy rival weight loss drugs following promising early stage trial data.
Related Posts
European leaders set to hold emergency summit on Ukraine
The UK PM, who is expected to attend, said it was a “once in a generation moment for our national…
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month
The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s…
Oil alliance OPEC+ zeroes in on group compliance after postponing output hike
The OPEC+ alliance is once more angling in on group compliance with oil output cuts, amid overproduction from heavyweight members…